EndoRotor® Features


  • Used clinically to facilitate EMR lateral margin resection
  • Potentially replace multiple 
instruments and eliminate instruments exchange time
  • Non-thermal mechanical resection of persistent adenoma
  • Energy based devices = unintended thermal injury to adjacent tissue … EndoRotor® = non-thermal
  • Designed to address flat tissue by suctioning 
and cutting in one motion
  • Designed to address the challenges of tissue bridges


Biopsy Forceps 2.0-2.5mm vs. EndoRotor® 2.0-2.5mm



Preclinical Testing & Pathology Results


Standard Bx Forceps

Morphological findings in EndoRotor® obtained Fundic Gland Giant Polyp with high-grade dysplasia (left) shows the characteristics and nuclear features (nuclear stratification, round nuclei, prominent nucleoli) needed for diagnosis and is comparable to standard biopsy forceps (right).


Advancement in Endoscopic Tools



  • How does the EndoRotor® work?

    The EndoRotor® has a rotating blade that cuts tissue that is drawn into the device via suction. The sample is then transported via suction to a Specimen Trap.

  • How does the EndoRotor® help me? What are the advantages over how I perform resection today?

    The incidence of incomplete resection during EMR is well documented throughout clinical literature. Because of its design the instrument allows the user to remove residual tissue including lateral margins or in secondary procedures for persistent adenoma. The EndoRotor® is a versatile tool that is not limited by tissue morphology.

  • What about pathological specimens?

    The EndoRotor® has FDA clearance for use by gastroenterologists to resect and remove residual tissue from the peripheral margins following Endoscopic Mucosal Resection (EMR). Procedures completed by physicians globally routinely involves specimen evaluated by pathologists without challenge.

  • What about margins?

    In ongoing clinical studies research shows physicians can resect lateral to a lesion using the EndoRotor® in order to address lateral margin. The device is indicated for tissue in the lateral margin otherwise not intended for biopsy.

  • What about perforation or bleeding?

    The EndoRotor® has been in use globally since 2016. Prophylactic epinephrine helps to mitigate bleeding risk. Perforation risk is within the standards of reported literature.

  • Where can I use the device?

    Currently the EndoRotor® has been approved for CE Mark in Europe for Resection of Alimentary tract mucosa. Recently the EndoRotor® received FDA clearance for use ancillary to EMR to ensure cleanup of the sites margins and persistent tissue.

MKT-0011 REV F